A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma.

Therapeutics and Clinical Risk Management
Teru HideshimaKenneth C Anderson

Abstract

Lenalidomide (also known as Revlimid((R)), CC-5013) is an immunomodulatory derivative of thalidomide and has more potent anti-tumor and anti-inflammatory effects than thalidomide. The molecular mechanisms of anti-tumor activity of lenalidomide have been extensively studied in multiple myeloma (MM) both preclinical models and in clinical trials. Lenalidomide: directly triggers growth arrest and/or apoptosis of drug resistant MM cells; inhibits binding of MM cells to bone marrow (BM) extracellular matrix proteins and stromal cells; modulates cytokine secretion and inhibits angiogenesis in the BM milieu; and augments host anti-tumor immunity. Lenalidomide achieved responses in patients with relapsed refractory MM. Moreover, lenalidomide with dexamethasone (Dex) demonstrates more potent anti-MM activities than Dex both in vitro and in randomized phase III clinical trials. Specifically, the combination improved overall and extent of response, as well as prolonged time to progression and overall survival, resulting in FDA approval of lenalidomide with Dex for therapy MM relapsing after prior therapy.

Citations

Apr 21, 2010·Medical Oncology·Thomas ReskeNikhil C Munshi
Apr 11, 2015·Future Oncology·María J Cejalvo, Javier de la Rubia
Nov 26, 2014·Nature Reviews. Clinical Oncology·Meletios A DimopoulosKenneth C Anderson
Nov 7, 2019·Biomolecules·Javad Sharifi-RadWilliam C Cho
Nov 20, 2008·Current Treatment Options in Oncology·Peter H Wiernik
Apr 11, 2020·Clinical Case Reports·Rajeev RamakrishnaTerry Golombick
Jul 17, 2018·Current Medicinal Chemistry·Sureyya Olgen, Lakshmi P Kotra
Aug 9, 2018·Future Medicinal Chemistry·Krzysztof Z Łączkowski, Angelika Baranowska-Łączkowska
Dec 5, 2008·Expert Opinion on Investigational Drugs·George J Brewer
Feb 20, 2010·Medical Oncology·Jacob P LaubachKenneth C Anderson
Jan 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R BerensonRobert Vescio
May 27, 2009·Journal of Pharmaceutical and Biomedical Analysis·Zhi-Yi ZhangVikram V Kansra

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent spot
nuclear translocation

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis